The transcription factor GATA-3 controls the expression and production of IL-3, IL-5, and IL-13, which is essential for type 2 inflammation and is overexpressed in patients with CRSwNP, asthma, and atopic eczema [157]. The gene discussed is IL5; the disease is chronic rhinosinusitis with nasal polyps.